Global Oral Transmucosal Drugs Market
According to Intent Market Research, the Oral Transmucosal Drugs Market is expected to grow from USD 4.3 Billion in 2024-e at a CAGR of 8.0% to touch USD 6.8 Billion by 2030. The Oral Transmucosal Drugs Market is dominated by key players such as Pfizer Inc., Cephalon Inc., Teva Pharmaceuticals, Mundipharma, Subutex Pharmaceuticals, and BioDelivery Sciences International Inc.